Alex Therapeutics is a digital therapeutics (DTx) company based in Stockholm which designs and develops Software-as-a-Medical-Devices. With the proven “Alex DTx Platform”, expertise in artificial intelligence and evidence-based psychology, Alex Therapeutics is uniquely positioned to deliver cutting-edge and reliable DTx products. Alex Therapeutics partners with pharmaceutical companies to develop and deliver DTx treatments and has a strategic commercial partnership with the global pharmaceutical company Pfizer. The initial focus of the Pfizer partnership is one of Alexs’ DTx products, a digital therapy called Eila® treating nicotine addiction.

Year of investment
2022
Sector
Digital Therapeutics (DTx)
Location
Stockholm, Sweden
Website
http://alextherapeutics.com/